KL
ASBPW

KIM LLC’s Aspire Biopharma Warrant ASBPW Stock Holding History

KIM LLC’s Portfolio ASBPW Stock Details ASBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100,000
Closed -$4.49K – 146
2024
Q2 		$4.49K Hold
100,000
– – ﹤0.01% 192
2024
Q1 		$3.01K Hold
100,000
– – ﹤0.01% 216
2023
Q4 		$6K Hold
100,000
– – ﹤0.01% 256
2023
Q3 		$5K Hold
100,000
– – ﹤0.01% 334
2023
Q2 		$5.5K Hold
100,000
– – ﹤0.01% 354
2023
Q1 		$4.18K Hold
100,000
– – ﹤0.01% 473
2022
Q4 		$8K Hold
100,000
– – ﹤0.01% 479
2022
Q3 		$15K Hold
100,000
– – ﹤0.01% 581
2022
Q2 		$12K Buy
+100,000
New +$21.8K ﹤0.01% 680

Other funds holding ASBPW

AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

KIM LLC's ASBPW Position: Q3 2024 in Review

KIM LLC sold out of Aspire Biopharma Warrant (ASBPW) in Q3 2024, closing a stake of 100,000 shares — an estimated $4.49K sold.

KIM LLC first reported a position in ASBPW in Q2 2022 and held it in 9 quarters. The position peaked at $15K in Q3 2022. 30 funds tracked by Wall St. Rank hold ASBPW as of Q3 2024.

  • KIM LLC reported no remaining Aspire Biopharma Warrant position as of Q3 2024 after selling out during the quarter.
  • KIM LLC sold 100,000 Aspire Biopharma Warrant shares in Q3 2024, an estimated $4.49K.
  • KIM LLC first reported a position in Aspire Biopharma Warrant in Q2 2022 and held it in 9 quarters.
  • KIM LLC's Aspire Biopharma Warrant position peaked at $15K in Q3 2022.
  • 30 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q3 2024.

Based on KIM LLC's 13F filing for Q3 2024, filed 13 Nov 2024.